Con: Vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease-Reference-Cited by-同舟云学术

Con: Vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease

Published:2015-02-23 Issue:3 Volume:30 Page:352-357
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Zoccali C.,London G.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/30/3/352/6880880/gfv021.pdf

Reference41 articles.

1. More Evidence for Coronary Calcium as a Measure of Cardiovascular Risk

2. Mechanisms of arterial calcifications and consequences for cardiovascular function

3. Surrogate Endpoints And FDA’s Accelerated Approval Process

4. Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction

5. Molecular Mechanisms of Vascular Calcification

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of artificial intelligence to chronic kidney disease mineral bone disorder;Clinical Kidney Journal;2024-06

2. Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview;Life;2024-03-21

3. Vascular Calcification and Calciphylaxis in Peritoneal Dialysis Patients;Nolph and Gokal's Textbook of Peritoneal Dialysis;2023

4. Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis;Biomolecules;2022-04-08

5. Fibroblast growth Factor-23 in pre-dialysis chronic kidney disease patients and its correlation with carotid artery calcification;Indian Journal of Nephrology;2022